Paxlovid effective in reducing risk of long COVID symptoms: study
Paxlovid effective in reducing risk of long COVID symptoms: study
(The Hill) – A recent preprint study found that Pfizer’s COVID-19 antiviral Paxlovid may be effective in reducing the risk of developing long COVID in patients recovering from coronavirus infections.
The study, funded by the Department of Veterans Affairs (VA), looked through the VA’s healthcare databases and identified individuals who tested positive for COVID-19 between March and June…